Edith A. Perez, MD | Authors

Articles

Genomic Analysis of the NCCTG N9831 Adjuvant Trastuzumab Trial

August 05, 2014

Edith A. Perez, MD, Breast Cancer: Giant of Cancer Care; deputy director at large, Mayo Clinic Cancer Center, Serene M. and Frances C. Durling professor of Medicine, Division of Hematology/Oncology, discusses a genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial.